Finzati - Logo
PHIO logo

Phio Pharmaceuticals Corp.

PHIO • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$11.44M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 49.37Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$11.44M
52W Range0.81 - 4.19
Beta0.81
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio49.37
Quick Ratio49.37
Volume99.89K

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 49.37Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 5/10/2012
Industry: Biotechnology
P/B i: 0.31
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 49.37
Quick Ratio: 49.37
Status: Good

Insider Transactions

Recent executive and insider activity

Bitterman Robert J
Transaction: 06/26/2026
BUY
Change
+10,000
Price
$0.99
Filing
06/29/2026
Type
BUY
Bitterman Robert J
Transaction: 02/05/2026
BUY
Change
+120,000
Price
Not reported
Filing
02/06/2026
Type
BUY
BRADFORD PATRICIA A
Transaction: 02/05/2026
BUY
Change
+18,500
Price
Not reported
Filing
02/06/2026
Type
BUY